U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
SUDUBRILIMAB
INN  
Official Name English
SUDUBRILIMAB (IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CD274 (PROGRAMMED DEATH LIGAND 1, PDL1, PD-L1, B7 HOMOLOG 1, B7H1)), MONOCLONAL ANTIBODY)
Preferred Name English
sudubrilimab [INN]
Common Name English
Code System Code Type Description
NCI_THESAURUS
C188652
Created by admin on Wed Apr 02 12:12:23 GMT 2025 , Edited by admin on Wed Apr 02 12:12:23 GMT 2025
PRIMARY
CAS
2387417-06-1
Created by admin on Wed Apr 02 12:12:23 GMT 2025 , Edited by admin on Wed Apr 02 12:12:23 GMT 2025
PRIMARY
SMS_ID
300000038023
Created by admin on Wed Apr 02 12:12:23 GMT 2025 , Edited by admin on Wed Apr 02 12:12:23 GMT 2025
PRIMARY
FDA UNII
X7KV7WP4ET
Created by admin on Wed Apr 02 12:12:23 GMT 2025 , Edited by admin on Wed Apr 02 12:12:23 GMT 2025
PRIMARY
INN
11649
Created by admin on Wed Apr 02 12:12:23 GMT 2025 , Edited by admin on Wed Apr 02 12:12:23 GMT 2025
PRIMARY
ACTIVE MOIETY
SUDUBRILIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966